1)財団法人前立腺研究財団:前立腺がん検診市町村別実施状況―2009年5月調査,財団法人前立腺研究財団,東京,2010
2)Ito K, Ichinose Y, Kubota Y, et al:Clinicopathological features of prostate cancer detected by transrectal ultrasonography-guided systematic six-sextant biopsy. Int J Urol 4:474-479, 1997
3)Imai K, Ichinose Y, Kubota Y, et al:Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer. J Urol 154:1085-1089, 1995
4)Catalona WJ, Richie JP, Ahmann FR, et al:Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer:results of a multicenter clinical trial of 6,630 men. J Urol 151:1283-1290, 1994
5)Gustafsson O, Norming U, Almgard LE, et al:Diagnostic methods in the detection of prostate cancer:a study of a randomly selected population of 2,400 men. J Urol 148:1827-1831, 1992
6)Heidenreich A, Abrahamsson PA, Artibani, W et al:Early detection of prostate cancer:European Association of Urology recommendation. Eur Urol 64:347-354, 2013
7)福多 史,舛森 直,田中吉則,他:下部尿路症状を主訴とする受診症例における前立腺癌発見率.臨泌59:133-138,2005
8)Brawn PN, Johnson EH, Speights VO, et al:Incidence, racial differences, and prognostic significance of prostate carcinomas diagnosed with obstructive symptoms. Cancer 74:1607-1611, 1994